Nicotinamide Mononucleotide, an NAD+ Precursor, Rescues Age-Associated Susceptibility to AKI in a Sirtuin 1–Dependent Manner
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
The rapid growth of an aging population creates challenges regarding age-related diseases, including AKI, for which both the prevalence and death rate increase with age. The molecular mechanism by which the aged kidney becomes more susceptible to acute injury has not been completely elucidated. In this study, we found that, compared with the kidneys of 3-month-old mice, the kidneys of 20-month-old mice expressed reduced levels of the renal protective molecule sirtuin 1 (SIRT1) and its cofactor NAD + . Supplementation with nicotinamide mononucleotide (NMN), an NAD + precursor, restored renal SIRT1 activity and NAD + content in 20-month-old mice and further increased both in 3-month-old mice. Moreover, supplementation with NMN significantly protected mice in both age groups from cisplatin-induced AKI. SIRT1 deficiency blunted the protective effect of NMN, and microarray data revealed that c-Jun N-terminal kinase (JNK) signaling activation associated with renal injury in SIRT1 heterozygotes. In vitro , SIRT1 attenuated the stress response by modulating the JNK signaling pathway, probably via the deacetylation of a JNK phosphatase, DUSP16. Taken together, our findings reveal SIRT1 as a crucial mediator in the renal aging process. Furthermore, manipulation of SIRT1 activity by NMN seems to be a potential pharmaceutical intervention for AKI that could contribute to the precise treatment of aged patients with AKI.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, they have demonstrated beneficial pharmacological activities in acute renal failure [28], anti-inflammatory [29–31], cardio and vasoprotective actions [32–35], telomere lengthening [36, 37•], extend lifespan and promote health in various organisms, from yeasts to mammals [10, 14, 15, 38].”
From NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health (2023) · cites this paper as [28]
In the citing paper
“NMN enhances mitochondrial function in various organs, including skeletal muscle201, kidney202–204, liver203, heart205, eyes206, brain161 and the cardiovascular system207, and can mitigate oxidative stress in the vasculature208, including improvements in neurovascular coupling responses in the aged cortex of the brain209.”
From NAD+ metabolism and its roles in cellular processes during ageing (2021) · cites this paper as [204]
Citations
Cites
Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
Kaeberlein, M., McVey, M., & Guarente, L. (1999) · Genes & Development · doi:10.1101/gad.13.19.2570 · Cited by 2,253
Stereological Methods. Practical methods for biological morphometry
Weibel, E. R. (1979) · Academic Press eBooks · Cited by 1,994
Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes
Milne, J. C., Lambert, P. D., Schenk, S., Carney, D. P., Smith, J. J., Gagne, D. J., Jin, L., Boss, O., Perni, R. B., Vu, C. B., et al. (2007) · Nature · doi:10.1038/nature06261 · Cited by 1,707
Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans
Tissenbaum, H. A., & Guarente, L. (2001) · Nature · doi:10.1038/35065638 · Cited by 1,603
Practical methods for biological morphometry
Weibel, E. R. (1979) · Academic Press eBooks · Cited by 1,563
Gomes, A. P., Price, N. L., Ling, A. J. Y., Moslehi, J. J., Montgomery, M. K., Rajman, L., White, J. P., Teodoro, J. S., Wrann, C. D., Hubbard, B. P., et al. (2013) · Cell · doi:10.1016/j.cell.2013.11.037 · Cited by 1,482
NAD+ and sirtuins in aging and disease
Imai, S.-I., & Guarente, L. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.04.002 · Cited by 1,481
Sir2 mediates longevity in the fly through a pathway related to calorie restriction
Rogina, B., & Helfand, S. L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404184101 · Cited by 1,361
Yoshino, J., Mills, K. F., Yoon, M. J., & Imai, S.-I. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.014 · Cited by 1,340
Cited by
NAD+ metabolism and its roles in cellular processes during ageing
Covarrubias, A. J., Perrone, R., Grozio, A., & Verdin, E. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00313-x · Cited by 1,617
NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential
Xie, N., Zhang, L., Gao, W., Huang, C., Huber, P. E., Zhou, X., Li, C., Shen, G., & Zou, B. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00311-7 · Cited by 1,052
NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR
Yoshino, J., Baur, J. A., & Imai, S.-I. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.11.002 · Cited by 1,061
“In addition to its anti-diabetic and neurological effects, NMN administration inhibits acute renal injury in a SIRT1-dependent manner (Guan et al., 2017), heart failure (Karamanlidis et al.”
InfluentialThe sirtuin family in health and disease
Wu, Q.-J., Zhang, T.-N., Chen, H.-H., Yu, X.-F., Lv, J.-L., Liu, Y.-Y., Liu, Y.-S., Zheng, G., Zhao, J.-Q., Wei, Y.-F., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01257-8 · Cited by 862
Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence
Rajman, L., Chwalek, K., & Sinclair, D. A. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.02.011 · Cited by 865
NAD+ homeostasis in health and disease
Katsyuba, E., Romani, M., Hofer, D., & Auwerx, J. (2020) · Nature Metabolism · doi:10.1038/s42255-019-0161-5 · Cited by 627
Cisplatin nephrotoxicity: new insights and therapeutic implications
Tang, C., Livingston, M. J., Safirstein, R., & Dong, Z. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00631-7 · Cited by 548
Role of NAD+ in regulating cellular and metabolic signaling pathways
Amjad, S., Nisar, S., Bhat, A. A., Shah, A. R., Frenneaux, M. P., Fakhro, K., Haris, M., Reddy, R., Patay, Z., Baur, J., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101195 · Cited by 384
Sirtuins in Renal Health and Disease
Morigi, M., Perico, L., & Benigni, A. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017111218 · Cited by 349
CD38 ecto-enzyme in immune cells is induced during aging and regulates NAD+ and NMN levels
Chini, C. C. S., Peclat, T. R., Warner, G. M., Kashyap, S., Espindola-Netto, J. M., de Oliveira, G. C., Gomez, L. S., Hogan, K. A., Tarragó, M. G., Puranik, A. S., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-00298-z · Cited by 349
The Multi-faceted Ecto-enzyme CD38: Roles in Immunomodulation, Cancer, Aging, and Metabolic Diseases
Hogan, K. A., Chini, C. C. S., & Chini, E. N. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01187 · Cited by 337
Kidney physiology and susceptibility to acute kidney injury: implications for renoprotection
Scholz, H., Boivin, F. J., Schmidt-Ott, K. M., Bachmann, S., Eckardt, K.-U., Scholl, U. I., & Persson, P. B. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-021-00394-7 · Cited by 314
NAD+ homeostasis in renal health and disease
Ralto, K. M., Rhee, E. P., & Parikh, S. M. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0216-6 · Cited by 291
The Role of PGC-1α and Mitochondrial Biogenesis in Kidney Diseases
Fontecha-Barriuso, M., Martin-Sanchez, D., Martinez-Moreno, J., Monsalve, M., Ramos, A., Sanchez-Niño, M., Ruiz-Ortega, M., Ortiz, A., & Sanz, A. (2020) · Biomolecules · doi:10.3390/biom10020347 · Cited by 294
Castro-Portuguez, R., & Sutphin, G. L. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.110841 · Cited by 281
Mitochondria in Sepsis-Induced AKI
Sun, J., Zhang, J., Tian, J., Virzì, G. M., Digvijay, K., Cueto, L., Yin, Y., Rosner, M. H., & Ronco, C. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018111126 · Cited by 257
The Pharmacology of CD38/NADase: An Emerging Target in Cancer and Diseases of Aging
Chini, E. N., Chini, C. C. S., Espindola Netto, J. M., de Oliveira, G. C., & van Schooten, W. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.02.001 · Cited by 227
“Experimental “NAD boosting” or “NAD replacement” can be accomplished via administration of NAD precursors such NMN, NR and derivatives of vitamin B3, or via inhibition of NAD-degrading enzymes [1-31].”
The JNK Signaling Pathway in Renal Fibrosis
Grynberg, K., Ma, F. Y., & Nikolic-Paterson, D. J. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00829 · Cited by 223
Modulating NAD + metabolism, from bench to bedside
Katsyuba, E., & Auwerx, J. (2017) · The EMBO Journal · doi:10.15252/embj.201797135 · Cited by 221
Nicotinamide mononucleotide (NMN) as an anti-aging health product – Promises and safety concerns
Nadeeshani, H., Li, J., Ying, T., Zhang, B., & Lu, J. (2022) · Journal of Advanced Research · doi:10.1016/j.jare.2021.08.003 · Cited by 208
Transition of acute kidney injury to chronic kidney disease: role of metabolic reprogramming
Zhu, Z., Hu, J., Chen, Z., Feng, J., Yang, X., Liang, W., & Ding, G. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155194 · Cited by 196
The Signaling of Cellular Senescence in Diabetic Nephropathy
Xiong, Y., & Zhou, L. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7495629 · Cited by 185
Acute Kidney Injury and Progression of Diabetic Kidney Disease
Yu, S. M.-W., & Bonventre, J. V. (2018) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2017.12.005 · Cited by 175
Hong, W., Mo, F., Zhang, Z., Huang, M., & Wei, X. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00246 · Cited by 174
McReynolds, M. R., Chellappa, K., & Baur, J. A. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.110888 · Cited by 163
Gasdermin E deficiency attenuates acute kidney injury by inhibiting pyroptosis and inflammation
Xia, W., Li, Y., Wu, M., Jin, Q., Wang, Q., Li, S., Huang, S., Zhang, A., Zhang, Y., & Jia, Z. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-03431-2 · Cited by 165
The multifaceted role of kidney tubule mitochondrial dysfunction in kidney disease development
Doke, T., & Suszták, K. (2022) · Trends in Cell Biology · doi:10.1016/j.tcb.2022.03.012 · Cited by 181
The role of NAD+ metabolism and its modulation of mitochondria in aging and disease
Yusri, K., Jose, S., Vermeulen, K. S., Tan, T. C. M., & Sorrentino, V. (2025) · npj Metabolic Health and Disease · doi:10.1038/s44324-025-00067-0 · Cited by 220
Chini, C., Hogan, K. A., Warner, G. M., Tarragó, M. G., Peclat, T. R., Tchkonia, T., Kirkland, J. L., & Chini, E. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.03.199 · Cited by 138
Chen, L., Wang, Y., Li, S., Zuo, B., Zhang, X., Wang, F., & Sun, D. (2020) · Theranostics · doi:10.7150/thno.43315 · Cited by 138
Giroud-Gerbetant, J., Joffraud, M., Giner, M. P., Cercillieux, A., Bartova, S., Makarov, M. V., Zapata-Pérez, R., Sánchez-García, J. L., Houtkooper, R. H., Migaud, M. E., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.013 · Cited by 129
NMN recruits GSH to enhance GPX4-mediated ferroptosis defense in UV irradiation induced skin injury
Feng, Z., Qin, Y., Huo, F., Jian, Z., Li, X., Geng, J., Li, Y., & Wu, J. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166287 · Cited by 130
The road ahead for health and lifespan interventions
Gonzalez-Freire, M., Diaz-Ruiz, A., Hauser, D., Martinez-Romero, J., Ferrucci, L., Bernier, M., & de Cabo, R. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101037 · Cited by 118
“Renal SIRT1 activity and NAD+ content are restored upon NMN treatment of young and 20-month-old mice (Guan et al., 2017), and NMN can synergize with exercise to delay skeletal muscle dysfunction in aging rats via increase in SIRT1 activity (Pajk et al., 2017).”
BackgroundKey Signaling Pathways in Aging and Potential Interventions for Healthy Aging
Yu, M., Zhang, H., Wang, B. Z., Zhang, Y., Zheng, X., Shao, B., Zhuge, Q., & Jin, K. (2021) · Cells · doi:10.3390/cells10030660 · Cited by 131
Song, J., Li, J., Yang, F., Ning, G., Zhen, L., Wu, L., Zheng, Y., Zhang, Q., Lin, D., Xie, C., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1569-2 · Cited by 118
NAD+ precursor supplementation prevents mtRNA/RIG-I-dependent inflammation during kidney injury
Doke, T., Mukherjee, S., Mukhi, D., Dhillon, P., Abedini, A., Davis, J. G., Chellappa, K., Chen, B., Baur, J. A., & Suszták, K. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00761-7 · Cited by 129
NAD+ flux is maintained in aged mice despite lower tissue concentrations
McReynolds, M. R., Chellappa, K., Chiles, E., Jankowski, C., Shen, Y., Chen, L., Descamps, H. C., Mukherjee, S., Bhat, Y. R., Lingala, S. R., et al. (2021) · Cell Systems · doi:10.1016/j.cels.2021.09.001 · Cited by 112
Tammaro, A., Kers, J., Scantlebery, A. M. L., & Florquin, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01346 · Cited by 113
Cellular Senescence in Kidney Fibrosis: Pathologic Significance and Therapeutic Strategies
Xu, J., Zhou, L., & Liu, Y. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.601325 · Cited by 123
Alegre, G. F. S., & Pastore, G. M. (2023) · Current Nutrition Reports · doi:10.1007/s13668-023-00475-y · Cited by 101
Reduction in podocyte SIRT1 accelerates kidney injury in aging mice
Chuang, P. Y., Cai, W., Li, X., Fang, L., Xu, J., Yacoub, R., He, J. C., & Lee, K. (2017) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00255.2017 · Cited by 98
Mitochondrial Metabolism in Acute Kidney Injury
Clark, A. J., & Parikh, S. M. (2020) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2020.01.002 · Cited by 100
NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis
Braidy, N., & Liu, Y. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.110831 · Cited by 103
Yasuda, I., Hasegawa, K., Sakamaki, Y., Muraoka, H., Kawaguchi, T., Kusahana, E., Ono, T., Kanda, T., Tokuyama, H., Wakino, S., et al. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020081188 · Cited by 95
Nicotinamide reduces renal interstitial fibrosis by suppressing tubular injury and inflammation
Zheng, M., Cai, J., Liu, Z., Shu, S., Wang, Y., Tang, C., & Dong, Z. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14285 · Cited by 94
Targeting energy pathways in kidney disease: the roles of sirtuins, AMPK, and PGC1α
Clark, A. J., & Parikh, S. M. (2020) · Kidney International · doi:10.1016/j.kint.2020.09.037 · Cited by 101
The CD38 glycohydrolase and the NAD sink: implications for pathological conditions
Zeidler, J. D., Hogan, K. A., Agorrody, G., Peclat, T., Kashyap, S., Kanamori, K. S., Gomez, L. S., Mazdeh, D. Z., Warner, G. M., Thompson, K. L., et al. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00451.2021 · Cited by 97
Peritubular Capillary Rarefaction: An Underappreciated Regulator of CKD Progression
Kida, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218255 · Cited by 105
Pathological mechanisms of kidney disease in ageing
Yamamoto, T., & Isaka, Y. (2024) · Nature Reviews Nephrology · doi:10.1038/s41581-024-00868-4 · Cited by 113
Lynch, M. R., Tran, M. T., & Parikh, S. M. (2018) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00263.2017 · Cited by 85
Therapeutic potential of boosting NAD+ in aging and age-related diseases
Aman, Y., Qiu, Y., Tao, J., & Fang, E. F. (2018) · Translational Medicine of Aging · doi:10.1016/j.tma.2018.08.003 · Cited by 82
Mao, H., Wang, L., Xiong, Y., Jiang, G., & Liu, X. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/7444430 · Cited by 94
Mitochondrial GPX4 acetylation is involved in cadmium-induced renal cell ferroptosis
Guo, Y., Liang, N., Zhang, X., Ren, Y.-H., Wu, W.-Z., Liu, Z., He, Y.-Z., Zhang, Y.-H., Huang, Y., Zhang, T., et al. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103179 · Cited by 98
Zeng, Y., Guo, M., Wu, Q., Tan, X., Jiang, C., Teng, F., Chen, J., Zhang, F., Ma, X., Li, X., et al. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.08.018 · Cited by 109
Self-citationToward understanding genomic instability, mitochondrial dysfunction and aging
Fakouri, N. B., Hou, Y., Demarest, T. G., Christiansen, L. S., Okur, M. N., Mohanty, J. G., Croteau, D. L., & Bohr, V. A. (2019) · The FEBS Journal · doi:10.1111/febs.14663 · Cited by 77
Reduced nicotinamide mononucleotide is a new and potent NAD + precursor in mammalian cells and mice
Zapata‐Pérez, R., Tammaro, A., Schomakers, B. V., Scantlebery, A. M. L., Denis, S., Elfrink, H. L., Giroud‐Gerbetant, J., Cantó, C., López‐Leonardo, C., McIntyre, R. L., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202001826r · Cited by 72
Hu, L., Guo, Y., Song, L., Wen, H., Sun, N., Wang, Y., Qi, B., Liang, Q., Geng, J., Liu, X., et al. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.03.012 · Cited by 73
Sanchez-Contreras, M., Sweetwyne, M. T., Tsantilas, K. A., Whitson, J. A., Campbell, M. D., Kohrn, B. F., Kim, H. J., Hipp, M. J., Fredrickson, J., Nguyen, M. M., et al. (2023) · eLife · doi:10.7554/elife.83395 · Cited by 71
“In contrast, NMN is an NAD+ precursor molecule and acts by elevating NAD levels and providing additional substrate for mitochondrial ATP generation(Guan et al., 2017; Martin et al., 2017; Yoshino et al., 2011).”
BackgroundSirtuins at the Service of Healthy Longevity
Watroba, M., & Szukiewicz, D. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.724506 · Cited by 64
Fan, X., Wei, W., Huang, J., Liu, X., & Ci, X. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00264 · Cited by 67
Kong, Y., Xu, C., Liu, F., Tang, J., Zhang, Y., Zhang, X., Zhang, L., Zhang, T., Wang, Y., Su, M., et al. (2024) · Advanced Materials · doi:10.1002/adma.202310731 · Cited by 73
Jia, Y., Kang, X., Tan, L., Ren, Y., Qu, L., Tang, J., Liu, G., Wang, S., Xiong, Z., & Yang, L. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.649547 · Cited by 61
Self-citationTargeting Sirtuin1 to treat aging-related tissue fibrosis: From prevention to therapy
Han, X., Ding, C., Sang, X., Peng, M., Yang, Q., Ning, Y., Lv, Q., Shan, Q., Hao, M., Wang, K.-L., et al. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107983 · Cited by 72
Wu, K., Li, B., Lin, Q., Xu, W., Zuo, W., Li, J., Liu, N., Tu, T., Zhang, B., Xiao, Y., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119299 · Cited by 60
SIRT1 attenuates renal fibrosis by repressing HIF-2α
Li, P., Liu, Y., Qin, X., Chen, K., Wang, R., Yuan, L., Chen, X., Hao, C., & Huang, X. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00443-x · Cited by 61
Self-citationPi, C., Yang, Y. J., Sun, Y., Wang, H., Sun, H., Ma, M., Lin, L., Shi, Y., Li, Y., Li, Y., et al. (2019) · Aging · doi:10.18632/aging.101993 · Cited by 58
Fu, Y., Wang, Y. X., Liu, Y., Tang, C., Cai, J., Chen, G., & Dong, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.925738 · Cited by 62
He, S., Jiang, X., Yang, J., Wu, Y., Shi, J., Wu, X., Du, S., Zhang, Y., Gong, L., Dong, S., et al. (2023) · Pharmaceutical Biology · doi:10.1080/13880209.2023.2292256 · Cited by 56
Genes and Longevity of Lifespan
Bin-Jumah, M. N., Nadeem, M. S., Gilani, S. J., Al-Abbasi, F. A., Ullah, I., Alzarea, S. I., Ghoneim, M. M., Alshehri, S., Ud-Din, A., Murtaza, B. N., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031499 · Cited by 66
Sirtuins in kidney health and disease
Perico, L., Remuzzi, G., & Benigni, A. (2024) · Nature Reviews Nephrology · doi:10.1038/s41581-024-00806-4 · Cited by 61
Kumakura, S., Sato, E., Sekimoto, A., Hashizume, Y., Yamakage, S., Miyazaki, M., Ito, S., Harigae, H., & Takahashi, N. (2021) · Toxins · doi:10.3390/toxins13010050 · Cited by 49
Roles of NAD+ in Acute and Chronic Kidney Diseases
Morevati, M., Fang, E. F., Mace, M. L., Kanbay, M., Gravesen, E., Nordholm, A., Egstrand, S., & Hornum, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010137 · Cited by 51
Targeting Mitochondria and Metabolism in Acute Kidney Injury
Li, Y., Hepokoski, M., Gu, W., Simonson, T. S., & Singh, P. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10173991 · Cited by 48
Pharmacology and Potential Implications of Nicotinamide Adenine Dinucleotide Precursors
She, J., Sheng, R., & Qin, Z. (2021) · Aging and Disease · doi:10.14336/ad.2021.0523 · Cited by 53
Liu, J., Zong, Z., Zhang, W., Chen, Y., Wang, X., Shen, J., Yang, C., Liu, X., & Deng, H. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.702107 · Cited by 48
Roles of NAD + in Health and Aging
Lautrup, S., Hou, Y., Fang, E. F., & Bohr, V. A. (2023) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041193 · Cited by 58
NAD+ and cardiovascular diseases
Lin, Q., Zuo, W., Liu, Y., Wu, K., & Liu, Q. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.01.012 · Cited by 54
Nicotinamide mononucleotide production by fructophilic lactic acid bacteria
Sugiyama, K., Iijima, K., Yoshino, M., Dohra, H., Tokimoto, Y., Nishikawa, K., Idogaki, H., & Yoshida, N. (2021) · Scientific Reports · doi:10.1038/s41598-021-87361-1 · Cited by 46
Nicotinamide Adenine Dinucleotide in Aging Biology: Potential Applications and Many Unknowns
Bhasin, S., Seals, D. R., Migaud, M. E., Musi, N., & Baur, J. A. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad019 · Cited by 55
Gu, W., Wang, X., Zhao, H., Geng, J., Li, X., Zheng, K., Guan, Y., Hou, X., Wang, C., & Song, G. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174776 · Cited by 46
Self-citationHe, S., Gao, Q., Wu, X., Shi, J., Zhang, Y., Yang, J., Li, X., Du, S., Zhang, Y., & Yu, J. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17222 · Cited by 42
Surya, K., Manickam, N., Jayachandran, K. S., Kandasamy, M., & Anusuyadevi, M. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220559 · Cited by 49
Integrated Stress Response Potentiates Ponatinib-Induced Cardiotoxicity
Yan, G., Han, Z., Kwon, Y., Jousma, J., Nukala, S. B., Prosser, B. L., Du, X., Pinho, S., Ong, S., Lee, W. H., et al. (2024) · Circulation Research · doi:10.1161/circresaha.123.323683 · Cited by 43
Effect of NAD+ boosting on kidney ischemia-reperfusion injury
Morevati, M., Egstrand, S., Nordholm, A., Mace, M. L., Andersen, C. B., Salmani, R., Ølgaard, K., & Lewin, E. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252554 · Cited by 47
Fan, X., Wei, W., Huang, J., Peng, L., & Ci, X. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.579178 · Cited by 45
A systems-approach to NAD+ restoration
Conlon, N. J., & Ford, D. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114946 · Cited by 47
Resveratrol ameliorates muscle atrophy in chronic kidney disease via the axis of SIRT1/FoxO1
Wang, R., Yuan, W., Li, L., Lu, F., Zhang, L., Gong, H., & Huang, X. (2022) · Phytotherapy Research · doi:10.1002/ptr.7499 · Cited by 42
Self-citationAutophagy in Cisplatin Nephrotoxicity during Cancer Therapy
Hu, X., Ma, Z., Wen, L., Li, S., & Dong, Z. (2021) · Cancers · doi:10.3390/cancers13225618 · Cited by 38
Receptor-mediated mitophagy: An emerging therapeutic target in acute kidney injury
Dagar, N., Kale, A., Steiger, S., Anders, H., & Gaikwad, A. B. (2022) · Mitochondrion · doi:10.1016/j.mito.2022.08.004 · Cited by 41
Nicotinamide adenine dinucleotide emerges as a therapeutic target in aging and ischemic conditions
Hosseini, L., Vafaee, M. S., Mahmoudi, J., & Badalzadeh, R. (2019) · Biogerontology · doi:10.1007/s10522-019-09805-6 · Cited by 40
Wan, L., Li, S., Du, J., Li, A., Zhan, Y., Zhu, W., Zheng, P., Qiao, D., Nie, C., & Pan, Q. (2025) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.4c02366 · Cited by 38
Collier, J. B., & Schnellmann, R. G. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03391-z · Cited by 38
Role and Potential Mechanisms of Nicotinamide Mononucleotide in Aging
Rahman, S. U., Qadeer, A., & Wu, Z. (2024) · Aging and disease · doi:10.14336/ad.2023.0519-1 · Cited by 34
“In another study, NMN supplementation was shown to restore Sirt1and NAD + levels, ultimately protecting kidneys from age-related acute kidney injury (AKI) in a Sirt1-dependent manner [81].”
BackgroundMethodWang, Y., Wang, Y., Yang, M., & Ma, X. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111191 · Cited by 34
The Integrated RNA Landscape of Renal Preconditioning against Ischemia-Reperfusion Injury
Johnsen, M., Kubacki, T., Yeroslaviz, A., Späth, M. R., Mörsdorf, J., Göbel, H., Bohl, K., Ignarski, M., Meharg, C., Habermann, B. H., et al. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019050534 · Cited by 39
Peclat, T., Shi, B., Varga, J., & Chini, E. N. (2020) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000737 · Cited by 35
Liang, N., Guo, Y., Zhang, X., Ren, Y.-H., He, Y.-Z., Liu, Z., Xu, D., & Xu, S. (2024) · Advanced Science · doi:10.1002/advs.202404753 · Cited by 46
Metabolic reprogramming of CAR T cells: a new frontier in cancer immunotherapy
Frlic, T., & Pavlin, M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1688995 · Cited by 39
Chronic kidney disease attenuates the plasma metabolome response to insulin
Roshanravan, B., Zelnick, L. R., Djucovic, D., Gu, H., Alvarez, J. A., Ziegler, T. R., Gamboa, J. L., Utzschneider, K. M., Kestenbaum, B. R., Himmelfarb, J., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.122219 · Cited by 38
Porous Se@SiO2 nanospheres attenuate cisplatin-induced acute kidney injury via activation of Sirt1
Li, X., Wang, Q., Deng, G., Liu, Y., Wei, B., Liu, X., Bao, W., Wang, Q., & Wu, S. (2019) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2019.114704 · Cited by 33
Metadata
- Authors
- Guan, Y., Wang, S.-R., Huang, X.-Z., Xie, Q.-H., Xu, Y.-Y., Shang, D., & Hao, C.-M.
- Affiliations
- Fudan University (CN)
- Corresponding author
- Shang, Da
- Hao, Chuan-Ming
- Venue
- Journal of the American Society of Nephrology
- Published
- 2017-02-28
- Volume
- 28
- Issue
- 8
- Pages
- 2337-2352
- ISSN
- 1046-6673 (ISSN-L)
- 1533-3450
- PMC
- PMC5533221
- OpenAlex
- W2592892973
- Cited by
- 238
- References
- 53
- Citations by year
- 2026: 18 · 2025: 24 · 2024: 28 · 2023: 28 · 2022: 40 · 2021: 38 · 2020: 26 · 2019: 20 · 2018: 8 · 2017: 8
- FWCI
- 10.25
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Journal of the American Society of Nephrology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China
- Chinese Academy of Sciences
- Fudan University
- National Key Research and Development Program of China
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Chemotherapy-induced organ toxicity mitigation
- Keywords
- nicotinamide mononucleotide, NAD+ precursors, SIRT1, acute kidney injury, kidney aging, cisplatin nephrotoxicity, JNK signaling, DUSP16, NAD+ depletion, renal protection
- MeSH terms
- Age Factors, Animals, Disease Susceptibility, NAD, Nicotinamide Mononucleotide, JNK Mitogen-Activated Protein Kinases, Mice, Sirtuin 1, Acute Kidney Injury
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.